Skip to main content
. 2007 Oct 11;3(9):607–611. doi: 10.1016/j.nurpra.2007.08.004

Table 1.

Summary of Recommended Treatment Options for Outpatient Acute Bacterial Rhinosinusitis in Adults15

Initial presentationa Primary Option Alternative Option
Antibiotic use in past month? No; choose from Amoxicillin 1 g TID Yes; choose from
Cefdinir 300 mg Q12 h or 600 mg Q24 h Augmentin XR 2000/125 mg BID
Cefpodoxime 200 mg BID If allergic to penicillin, choose from
Cefprozil 250–500 mg BID Gatifloxacin 400 mg Q24 h
If allergic to penicillin, choose from Levofloxacin 750 mg Q24 h × 5 d
Moxifloxacin 400 mg Q24 h Moxifloxacin 400 mg Q24 h
Doxycycline100 mg BID
TMP-SMX (Bactrim DS), 1 tablet BID
Clarithromycin 500 mg BID or
Clarithromycin ER 1 g Q24 h
Clinical failure after 3 days of initial therapyb Mild or moderate disease, choose from Severe disease, choose from
Augmentin XR 2000/125 mg BID Gatifloxacin 400 mg Q24 h
Cefdinir 300 mg Q12 h or 600 mg Q24 h Levofloxacin 750mg Q24 h × 5 d
Cefpodoxime 200 mg BID Moxifloxacin 400 mg Q24 h
Cefprozil 250–500 mg BID

All regimens are for 10 days unless otherwise specified. TMP-SMX, trimethoprim and sulfamethoxazole; DS, double strength; ER, extended release.

a

Patients with fever and facial erythema are at increased risk of infection with Staphylococcus aureus, which warrants intravenous antibiotic therapy.

b

Consider referral to otolaryngologist for diagnostic aspiration and culture.